The significance of p53 and bcl-2 overexpression and other prognostic factors in transitional cell carcinoma of the bladder

International Urology and Nephrology

Volumn 38, Issue 2, 2006, Pages 231-236

  Touloupidis, Stavros ^a   Fatles, Georgios ^b   Kalaitzis, Christos ^a   Giatromanolaki, Alexandra ^a   Sivridis, Eythimyos ^a   Simopoulos, Konstantinos ^a   Rombis, Vassilios ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b Ippokration Hospital Thessaloniki   (Greece)

Author keywords

bcl 2; p53; Transitional cell carcinoma of the bladder

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; RECURRENCE RISK; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

AGE FACTORS; AGED; ANTIGENS, NEOPLASM; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECURRENCE; SEX FACTORS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 33746559191     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-005-4763-3     Document Type: Article

References (18)

1. H Tsujihashi A Nakanishi H Matsuda et al. 1991 Cell proliferation of human bladder tumors determined by BrdUrd and Ki-67 immunostaining J Urol 145 4 846-849 2005717 1:STN:280:By6C2s7ktVA%3D
2. B Li H Kanamaru S Noriki et al. 1998 Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder Urol Res 26 4 235-241 9759996 1:CAS:528:DyaK1cXlvV2mtb4%3D 10.1007/s002400050051
3. RT Vollmer PA Humphrey PE Swanson et al. 1998 Invasion of the bladder by transitional cell carcinoma: Its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor and bcl-2 Cancer 82 4 715-723 9477105 1:STN:280:DyaK1c7jsF2ksA%3D%3D 10.1002/(SICI)1097-0142(19980215)82:4<715::AID-CNCR15>3.0.CO;2-0
4. D Hockenbery G Nunez C Milliman et al. 1990 Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death Nature 348 6299 334-336 2250705 1:CAS:528:DyaK3MXit1ehuw%3D%3D 10.1038/348334a0
5. TJ Liukkonen PK Lipponen M Helle et al. 1997 Immunoreactivity of bcl-2, p53, and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group Urol Res 25 1 1-7 9079739 1:CAS:528:DyaK2sXitVentLg%3D 10.1007/BF00941899
6. EJ Kirsh DA Baunoch WM Stadler 1998 Expression of bcl-2 and bcl-x in bladder cancer J Urol 159 4 1348-1353 9507882 1:CAS:528:DyaK1cXms1equrk%3D 10.1016/S0022-5347(01)63614-0
7. L Nakopoulou C Vourlakou A Zervas et al. 1998 The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates Hum Pathol 29 2 146-154 9490274 1:STN:280:DyaK1c7jvFartA%3D%3D 10.1016/S0046-8177(98)90225-8
8. F Atug L Turkeri M Ozyurek et al. 1998 Bcl-2 and p53 overexpression as associated risk factors in transitional cell carcinoma of the bladder Int Urol Nephrol 30 4 455-461 9821049 1:STN:280:DyaK1M%2FjvVCqsg%3D%3D
9. D Ye H Li S Qian et al. 1998 Bcl-2/bax expression and p53 gene status in human bladder cancer: Relationship to early recurrence with intravesical chemotherapy after resection J Urol 160 6 Pt 1 2025-2028 9817315 1:CAS:528:DyaK1cXnsFCht70%3D discussion 2029
10. T Tony J-HC Wu L Ying-Huei et al. 2000 The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma J Urol 163 758-760 10.1016/ S0022-5347(05)67798-1
11. PK Lipponen S Aaltomaa M Eskelinen 1996 Expression of the apoptosis suppressing bcl-2 protein in transitional cell bladder tumors Histopathology 28 2 135-140 8834521 1:STN:280:BymH3s7ktl0%3D 10.1046/ j.1365-2559.1996.276322.x
12. FC Burkhard R Marwalder GN Thalmann UE Studer 1997 Immunoistochemical determination of p53 overexpression: An easy and readily available method to identify progression in superficial bladder cancer? Urol Res 25 Suppl 1 31-35 10.1007/BF00942045
13. Z Sinik T Alkibay O Ataoglu et al. 1997 Correlation of nuclear p53 overexpression with clinical and histopathological features of transitional cell bladder cancer Intl Urol Nephrol 29 25-31 1:STN:280:ByiA2cnmtFM%3D
14. C Cordon-Cardo J Sheinfeld G Dalbagni 1997 Genetic studies and molecular markers of bladder cancer Semin Surg Oncol 13 319-327 9259087 1:STN:280:ByiH3czns1Y%3D 10.1002/(SICI)1098-2388(199709/ 10)13:5<319::AID-SSU5>3.0.CO;2-G
15. MG Friedrich A Erbersolber H Schwaibold et al. 2000 Detection of loss of heterozygosity in the p53 tumor suppressor gene with PCR in the urineof patients with bladder cancer J Urol 163 1039-1042 10688045 1:CAS:528:DC%2BD3cXhsVSju7s%3D 10.1016/S0022-5347(05)67878-0
16. RT Vollmer PA Humprey PE Swanson et al. 1998 Invasion of the bladder by transitional cell carcinoma: Its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor and bcl-2 Cancer 82 715-723 9477105 1:STN:280:DyaK1c7jsF2ksA%3D%3D 10.1002/(SICI)1097-0142(19980215)82:4<715::AID-CNCR15>3.0.CO;2-0
17. T Liukkonen P Rajala M Raitanen et al. 1999 Prognostic value of MIB-1 score, p53, ECFr, mitotic index and papillary status in primary superficial bladder cancer: A prospective comparative study: The Finnbladder Group Eur Urol 36 393-400 10516448 1:STN:280:DyaK1MvkslKhsw%3D%3D 10.1159/000020039
18. D Esrig D Elmajian S Groshen et al. 1994 Accumulation of nuclear p53 and tumor progression in bladder cancer [see comments] New Engl J Med 331 1259-1264 7935683 1:STN:280:ByqD387lvFY%3D 10.1056/NEJM199411103311903